首页|重组人干扰素α2b凝胶联合保妇康栓对高危型宫颈HPV感染患者炎症因子水平及转阴率的影响

重组人干扰素α2b凝胶联合保妇康栓对高危型宫颈HPV感染患者炎症因子水平及转阴率的影响

扫码查看
目的 探讨高危型宫颈人乳头瘤病毒(HPV)感染患者采用保妇康栓联合重组人干扰素α2b治疗的临床疗效。方法 采用随机数字表法将2021年4月至2023年10月九江市濂溪区人民医院收治的120例高危型宫颈HPV感染患者分为观察组(60例)及对照组(60例)。两组于用药前均采用0。01%浓度的高锰酸钾溶液行外阴清洁,予以对照组重组人干扰素α2b治疗,在其基础上观察组联合保妇康栓治疗。对比两组临床疗效、炎症因子水平、免疫功能、HPV转阴率及不良反应。结果 相比于对照组治疗总有效率(73。33%),观察组治疗总有效率(93。33%)较高,差异有统计学意义(P<0。05)。相比于对照组,观察组治疗后白细胞介素-4水平较低,白细胞介素-12、干扰素-γ水平均较高,差异有统计学意义(P<0。05)。相比于对照组,观察组治疗后CD8+水平较低,CD4+、CD4+/CD8+水平高于对照组,差异有统计学意义(P<0。05)。观察组HPV转阴率为93。33%,高于对照组的70。00%,差异有统计学意义(P<0。05)。两组不良反应发生率比较,差异无统计学意义(P>0。05)。结论 采用重组人干扰素α-2b联合保妇康栓治疗高危型宫颈HPV感染疗效确切,有助于减轻机体炎症反应,提升免疫功能,利于提高HPV转阴率,安全可靠,具有较高的临床推广应用价值。
Effects of Recombinant Human Interferon α2b Gel Combined with Baofukang Suppository on the Levels of Inflammatory Factors and the Rate of Negative Conversion in High-risk Cervical HPV Infection Patients
Objective To investigate the clinical efficacy of bafukang suppository combined with recombinant human interferonα-2b gel in the treatment of high-risk cervical human papillomavirus(HPV)infection.Methods 120 patients with high-risk cervical HPV infection admitted to Lianxi District People's Hospital of Jiujiang from April 2021 to October 2023 were divided into observation group(60 cases)and control group(60 cases)by random number table method.Both groups were cleaned vulva with 0.01%potassium permanganate solution before medication,the control group was treated with recombinant human interferon α2b gel,and the observation group was treated with baofukang suppository on the basis of the control group.The clinical efficacy,levels of inflammatory factors,immune function,negative rate of HPV and adverse reactions were compared between the two groups.Results Compared with the control group(73.33%),the total effective rate of the observation group(93.33%)was higher,and the difference was statistically significant(P<0.05).Compared with the control group,the level of interleukin-4 in the study group after treatment was lower,and the levels of interleukin-12 and interferon-γ were higher,with statistical significances(P<0.05);the levels of CD8+in the observation group were lower after treatment,and the levels of CD4+and CD4+/CD8+were higher than those in the control group,with statistical significances(P<0.05).The negative conversion rate of HPV in the observation group was 93.33%,higher than that in the control group(70.00%),and the difference was statistically significant(P<0.05).There was no significant difference in the incidence of adverse reactions between the two groups(P>0.05).Conclusion Recombinant human interferon α2b gel combined with baofukang suppository has definite efficacy in the treatment of high-risk cervical HPV infection,which can help to reduce inflammation,improve immune function,and improve the negative rate of HPV.It is safe and reliable,and has high clinical application value.

High-risk human papillomavirusBaofukang suppositoryRecombinant human interferon α2bNegative conversion rateInflammatory factor

钟祥薇

展开 >

九江市濂溪区人民医院,江西九江 332005

高危型人乳头瘤病毒 保妇康栓 重组人干扰素α 2b 转阴率 炎症因子

2024

药品评价
江西省药学会

药品评价

影响因子:0.672
ISSN:1672-2809
年,卷(期):2024.21(6)